Ge Long Hui·2025-12-01 12:26Core Viewpoint - China Resources Pharmaceutical (03320.HK) announced that its non-wholly owned subsidiary, China Resources Pharmaceutical Commercial Group Co., Ltd. ("China Resources Commercial"), has received a registration acceptance notice from the National Association of Financial Market Institutional Investors regarding the proposed issuance of medium-term notes in the People's Republic of China [1] Group 1 - The notice is valid for two years from the date of issuance, allowing China Resources Commercial to issue medium-term notes totaling RMB 3 billion in installments during this period [1] - The expected proceeds from the proposed issuance will be used to repay interest-bearing debts of China Resources Commercial or its subsidiaries [1]